Navigation Links
FASEB Welcomes New President, William T. Talman, M.D.
Date:7/1/2010

BETHESDA, Md., July 1 /PRNewswire-USNewswire/ -- William T. Talman, M.D., assumed office as the 95th President of the Federation of American Societies for Experimental Biology (FASEB) on July 1, 2010. Talman is a Professor of Neurology and Neuroscience at the University of Iowa and is a practicing physician at the University Hospital and at the Iowa City Veterans Affairs (VA) hospital where he is the Chief of the Neurology Service. He will serve for one year as the leader of FASEB, a coalition of 23 member societies comprising more than 100,000 scientists and engineers.

"The opportunities for continued progress have never been greater, but those opportunities depend on adequate resources," Talman stated. "In 2009, supplemental appropriations from the American Recovery and Reinvestment Act (ARRA) restored purchasing power at the National Institutes of Health (NIH) and provided a timely investment in biomedical research across the nation. However, if we return to pre-ARRA funding levels in fiscal year 2011, we will have to curtail many promising research studies." As President, Talman will lead FASEB's advocacy efforts to encourage Congress and the Obama Administration to achieve the goal of sustainable funding for research.

A graduate of the University of Virginia School of Medicine, Talman's research focuses on the brain's control of the cardiovascular system, and his clinical specialty is autonomic dysfunction, for which he has been recognized by Best Doctors in America for the past eight years. Dr. Talman is the Past President of the International Society for Autonomic Neuroscience and past chair of the Public Affairs Committee of the American Physiological Society. He is also Associate Editor for Cellular and Molecular Neurobiology and has served as a reviewer for NIH Study Sections, VA Merit Review Boards, the National Science Foundation, and the American Heart Association.

Joseph C. LaManna, Ph.D., is FASEB's President-Elect and Fred D. Finkelman, M.D., the new Treasurer of the Federation. Dr. LaManna is a Professor of Physiology and Biophysics, Neurology and Neuroscience at the Case Western Reserve University School of Medicine and he has been involved as a cerebrovascular researcher for more than 30 years. Dr. Finkelman received his M.D. from Yale University and is a Professor of Medicine and Professor of Pediatrics at the University of Cincinnati College of Medicine.

FASEB is composed of 23 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB enhances the ability of scientists and engineers to improve — through their research — the health, well-being, and productivity of all people. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.


'/>"/>
SOURCE Federation of American Societies for Experimental Biology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FASEB Announces Recipient of the 2011 Excellence in Science Award
2. Cellectis to Present at the FASEB Summer Research Conference on Genome Engineering
3. FASEB Encourages NIGMS to Broaden Scientific Training Opportunities
4. Laureate Pharma Welcomes Three New Members to Business Development Team
5. Sundia Welcomes Professional U.S. Delegation
6. NovaMin Technology Inc. Welcomes New Board Member
7. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
8. Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P. Gailitis, M.D., F.A.C.S.
9. UCLA welcomes startup to new incubator space at California NanoSystems Institute
10. Boston Scientific Welcomes Launch of Syntax Score Website
11. Trusted LASIK Surgeons Welcomes LASIK Expert William Mathers, M.D. of the Casey Vision Correction Center in Portland, Oregon, to Its LASIK Directory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, the ... to industry to share solutions for the Biometric Exit ... Customs and Border Protection (CBP), explains that CBP intends ... departing the United States , in ... to defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
Breaking Biology News(10 mins):